Alaunos Therapeutics (TCRT) Gross Margin (2011)

Alaunos Therapeutics' (TCRT) quarterly Gross Margin came in at 5233.5% in Q3 2011, down 17.28% on a QoQ basis from 4462.5% in Q2 2011.

Alaunos Therapeutics (TCRT) Gross Margin (2011) Analysis & Trends

Alaunos Therapeutics (TCRT) has 1 years of Gross Margin data on file, last reported at 5233.5% in Q3 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	85.33%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	91.59%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	90.43%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	35.86%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	89.76%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	76.90%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	63.27%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	84.20%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Alaunos Therapeutics	4.28 Mn	4.16 Mn	-	-

Download Data

Date	Value
Sep 30, 2011	-5,233.50%
Jun 30, 2011	-4,462.50%